Iain B. McInnes
Impact in
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Immunology top 0.01%
- Psoriasis: Treatment and Pathogenesis
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
Papers in
- Rheumatology 388
- Rheumatoid Arthritis Research and Therapies 242
- Spondyloarthritis Studies and Treatments 182
- Systemic Lupus Erythematosus Research 80
- Immunology 247
- Psoriasis: Treatment and Pathogenesis 112
- Immune Cell Function and Interaction 35
- T-cell and B-cell Immunology 30
- Co-authors
- Georg Schett (22 shared papers)Foo Y. Liew (56 shared papers)Daniel Aletaha (13 shared papers)Josef S Smolen (1 shared paper)Naveed Sattar (56 shared papers)Bernard P. Leung (39 shared papers)Gary S. Firestein (6 shared papers)J. Alastair Gracie (27 shared papers)
- Journals
- Annals of the Rheumatic Diseases (200 papers)Lara D. Veeken (43 papers)The Journal of Immunology (33 papers)RMD Open (16 papers)The Lancet (13 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Iain B. McInnes
713 papers receiving 59.6k citations
Iain B. McInnes's Hit Papers
Peers
Comparison fields: 5 of 185
- Rheumatology 23.0k
- Immunology 21.2k
- Hematology 6.9k
- Dermatology 2.0k
- Immunology and Allergy 1.3k
Countries citing papers authored by Iain B. McInnes
This map shows the geographic impact of Iain B. McInnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iain B. McInnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iain B. McInnes more than expected).
Fields of papers citing papers by Iain B. McInnes
This network shows the impact of papers produced by Iain B. McInnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iain B. McInnes. The network helps show where Iain B. McInnes may publish in the future.
Co-authors
The 25 scholars most cited alongside Iain B. McInnes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 732 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Pathogenesis of Rheumatoid Arthritis Hit paper breakdown → | 2011 | 4285 |
| 2 | Rheumatoid arthritis Hit paper breakdown → | 2016 | 3552 |
| 3 | Cytokines in the pathogenesis of rheumatoid arthritis Hit paper breakdown → | 2007 | 2074 |
| 4 | Rheumatoid arthritis Hit paper breakdown → | 2018 | 1750 |
| 5 | Treating rheumatoid arthritis to target: recommendations of an international task force Hit paper breakdown → | 2010 | 1560 |
| 6 | The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention Hit paper breakdown → | 2015 | 1185 |
| 7 | Pathogenetic insights from the treatment of rheumatoid arthritis Hit paper breakdown → | 2017 | 1055 |
| 8 | EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis Hit paper breakdown → | 2009 | 1004 |
| 9 | Evidence that cytokines play a role in rheumatoid arthritis Hit paper breakdown → | 2008 | 931 |
| 10 | Immunopathogenesis of Rheumatoid Arthritis Hit paper breakdown → | 2017 | 895 |
| 11 | Disease-associated functions of IL-33: the new kid in the IL-1 family Hit paper breakdown → | 2010 | 861 |
| 12 | Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis Hit paper breakdown → | 2003 | 735 |
| 13 | Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2015 | 670 |
| 14 | Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial Hit paper breakdown → | 2013 | 638 |
| 15 | Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2004 | 635 |
| 16 | IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation Hit paper breakdown → | 2009 | 599 |
| 17 | Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis Hit paper breakdown → | 2015 | 593 |
| 18 | A proinflammatory role for IL-18 in rheumatoid arthritis Hit paper breakdown → | 1999 | 558 |
| 19 | IL-33 reduces the development of atherosclerosis Hit paper breakdown → | 2008 | 557 |
| 20 | Interleukin-18 Hit paper breakdown → | 2003 | 554 |
About Iain B. McInnes
Iain B. McInnes is a scholar working on Rheumatology, Immunology, Hematology, Oncology and Molecular Biology, having authored 732 papers that have together received 61.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (242 papers), Spondyloarthritis Studies and Treatments (182 papers), Autoimmune and Inflammatory Disorders Research (135 papers), Psoriasis: Treatment and Pathogenesis (112 papers), Systemic Lupus Erythematosus Research (80 papers), Cytokine Signaling Pathways and Interactions (51 papers), Immune Cell Function and Interaction (35 papers) and T-cell and B-cell Immunology (30 papers). The work is most often cited by research in Rheumatology (23.0k citations), Immunology (21.2k citations), Hematology (6.9k citations), Dermatology (2.0k citations) and Immunology and Allergy (1.3k citations). Iain B. McInnes has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Georg Schett, Foo Y. Liew, Daniel Aletaha, Josef S Smolen, Naveed Sattar, Bernard P. Leung, Gary S. Firestein, J. Alastair Gracie, Fionula M. Brennan and Stefan Siebert. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, The Journal of Immunology, RMD Open and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.